Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PC1V
|
||||
Former ID |
DIB010109
|
||||
Drug Name |
T-82
|
||||
Synonyms |
2-[2-(1-Benzylpiperidin-4-yl)ethyl]-9-methoxy-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one hemifumarate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Phase 2 | [526578] | ||
Structure |
Download2D MOL |
||||
Formula |
C26H29N3O2
|
||||
Canonical SMILES |
COC1=C2C(=NC3=CC=CC=C31)CN(C2=O)CCC4CCN(CC4)CC5=CC=CC=C<br />5
|
||||
InChI |
1S/C26H29N3O2/c1-31-25-21-9-5-6-10-22(21)27-23-18-29(26(30)24(23)25)16-13-19-11-14-28(15-12-19)17-20-7-3-2-4-8-20/h2-10,19H,11-18H2,1H3
|
||||
InChIKey |
UQMVECQBCVBXGA-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 142471-56-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [526578], [551871] | |
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.